[Selective synchronous inhalation and device for its conduction].
80 patients with exacerbation of chronic catarrhal and hypertrophic laryngitis were divided into groups who received selective synchroneous inhalation (SSI) only (n = 29), SSI plus common drug therapy (n = 29), SSI plus low-frequency magnetic field (n = 22). Control patients (n = 24) were given standard chemotherapy and inhalation. A statistically significant difference in duration of treatment was found between the control and study groups.
Suntsov
V V
VV
D000280:Administration, Inhalation; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D004338:Drug Combinations; D006801:Humans; D007827:Laryngitis / Q000188:drug therapy*; D008280:Magnetics; D009330:Nebulizers and Vaporizers; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D004338:Drug Combinations